Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only
  • 12 Tips for Traveling With Diabetes
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
Latest
Popular
Top Rated
Diabetes Health Reference Charts
Blood Sugar Archives
Print | Email | Share | Comments (1)

Neoral Comes to the Rescue of Kidney Transplant Patients


Jul 1, 1999

Kidney transplant patients who suffered high blood sugar when taking the antirejection drug tacrolimus (Prograf) demonstrated improvement when they were switched to the antirejection drug cyclosporin (Neoral).

Prograf and Neoral are both immunosuppressants given to patients receiving pancreas, kidney or liver transplants. According to studies presented recently at the 18th annual American Society of Transplantation (AST) meeting in East Hanover, New Jersey, Neoral was found to be an effective rescue therapy for kidney and liver recipients who are intolerant to Prograf.

Patients receiving kidney transplants were evaluated at seven transplant centers. Of the 96 kidney transplant patients receiving Prograf as their immunossuppressant, 9 patients (9 percent) experienced high blood sugar and were switched to Neoral. Nine other patients also had to discontinue Prograf because of symptoms which included neurotoxicity, nephrotoxicity, gastrointestinal tolerance and organ rejection.

Following the switch to Neoral, 73 percent of the patients suffering hyperglycemia showed improvement. Neurotoxicity was improved 83 percent and gastrointestinal tolerance was improved by 60 percent.

"The findings from this study demonstrate that Neoral is an effective therapy to rescue recipients who are intolerant of [Prograf] therapy," says Kenneth Brayman, MD, PhD, director of the pancreas transplant program at the Hospital of the University of Pennsylvania, and director of the renal transplant program at Children's Hospital of Philadelphia.


Categories: Blood Sugar, Kidney Care (Nephropathy), Medications



You May Also Be Interested In...


Click Here To View Or Post Comments

Comments 1 comment - Jul 1, 1999

©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.